ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
7,948.20
-1.81%
S&P ASX All Technology
3,629.80
-3.15%
Brent Oil
70.235
0.00%
US Dollar vs AUD
1.59084
0.00%
Bitcoin
86,300.87
-0.52%
Pepperstone
Advertisement
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Abivax SA (ABVX) Share Price

Abivax SA

Abivax SA (ABVX)

Abivax
7.91
-0.38
(-4.58%)
Closed 08 March 8:00AM
Delayed by 15 minutes
8.124
0.214
(2.71%)
After Hours: 11:59AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
7.91
Bid
7.20
Offer
12.78
Volume
242,592
7.90 Day's Range 8.275
0.00 52 Week Range 0.00
Market Cap
497.677M
Previous Close
8.29
Open
8.13
Last Trade
50000
@
8.05
(seq)
Last Trade Time
Financial Volume
US$ 1,961,724
VWAP
8.0865
Average Volume (3m)
-
Shares Outstanding
62,917,479
Dividend Yield
-
PE Ratio
-3.13
Earnings Per Share (EPS)
-2.35
Revenue
4.62M
Net Profit
-147.74M

About Abivax SA

Abivax is focused on developing innovative treatments that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. Abivax is focused on developing innovative treatments that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.abivax.com
Headquarters
Paris, Paris, Fra
Founded
-
Abivax SA is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ABVX. The last closing price for Abivax was US$8.29. Over the last year, Abivax shares have traded in a share price range of US$ 0.00 to US$ 0.00.

Abivax currently has 62,917,479 shares in issue. The market capitalisation of Abivax is US$521.59 million. Abivax has a price to earnings ratio (PE ratio) of -3.13.

Ask ADVFN Intelligence (AI)

ABVX Latest News

More News

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
11 January 2025
ABVX (-4.58%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
24 December 2024
ABVX (-4.58%)

Form EFFECT - Notice of Effectiveness
Edgar (US Regulatory)
27 November 2024
ABVX (-4.58%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
20 November 2024
ABVX (-4.58%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

ABVX - Frequently Asked Questions (FAQ)

What is the current Abivax share price?
The current share price of Abivax is US$ 7.91
How many Abivax shares are in issue?
Abivax has 62,917,479 shares in issue
What is the market cap of Abivax?
The market capitalisation of Abivax is USD 521.59M
What is the 1 year trading range for Abivax share price?
Abivax has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the PE ratio of Abivax?
The price to earnings ratio of Abivax is -3.13
What is the cash to sales ratio of Abivax?
The cash to sales ratio of Abivax is 100.14
What is the reporting currency for Abivax?
Abivax reports financial results in EUR
What is the latest annual turnover for Abivax?
The latest annual turnover of Abivax is EUR 4.62M
What is the latest annual profit for Abivax?
The latest annual profit of Abivax is EUR -147.74M
What is the registered address of Abivax?
The registered address for Abivax is 7-11 BOULEVARD HAUSSMANN, PARIS, PARIS, 75009
What is the Abivax website address?
The website address for Abivax is www.abivax.com
Which industry sector does Abivax operate in?
Abivax operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ABLVAble View Global Inc
US$ 1.73
(137.18%)
5.14M
SUNESUNation Energy Inc
US$ 0.402999
(127.55%)
482.05M
BTOGBit Origin Ltd
US$ 0.6117
(118.46%)
622.67M
DWTXDogwood Therapeutics Inc
US$ 6.63
(49.66%)
25.92M
KZIAKazia Therapeutics Ltd
US$ 1.1899
(40.80%)
4.5M
ALBTAvalon GloboCare Corporation
US$ 6.96
(-36.15%)
570.43k
SCNXScienture Holdings Inc
US$ 1.55
(-35.68%)
1.54M
ACXPAcurx Pharmaceuticals Inc
US$ 0.4572
(-29.88%)
1.13M
RETOReTo Eco Solutions Inc
US$ 5.42
(-27.73%)
108k
OCTOEightco Holdings Inc
US$ 1.08
(-27.03%)
332.1k
BTOGBit Origin Ltd
US$ 0.6117
(118.46%)
622.67M
SUNESUNation Energy Inc
US$ 0.402999
(127.55%)
482.05M
NVDANVIDIA Corporation
US$ 112.69
(1.92%)
341.94M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 10.675
(-0.70%)
143.04M
ICONIcon Energy Corporation
US$ 0.169898
(17.17%)
142.23M

ABVX Discussion

View Posts
Monksdream Monksdream 6 months ago
ABVX under $15

👍️0

Your Recent History

NASDAQ
ABVX
Abivax
BIT
UV4L3E
UniCredit Bank
BIT
I06825
Intesa Sanpaolo
BIT
1WDC
Westn Digital Dl 10
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads